Biopharmaceutical firms are rapidly adopting predictive analytics to address historical inefficiencies and cost overruns in clinical trial execution.
Algorithmic Patient Matching
Machine learning models analyzing electronic health records have shortened patient recruitment timelines by up to 30 percent. This data-driven targeting improves trial retention rates and accelerates time-to-market for specialized therapies.